Schwab Emerging Markets ETF vs. iShares World ETF: Which International ETF Is the Better Buy for Investors?

This is mostly a wrapper-choice story, not a fundamentals catalyst. The only real market mechanism is marginal flow: URTH tends to recycle capital into the same mega-cap tech complex already crowded in U.S. portfolios, while SCHE is the cleaner expression of EM beta and therefore more sensitive to the dollar, China policy, and Taiwan risk than to simple valuation arguments.

The fee/yield advantage for SCHE matters only for patient allocators; over 1-3 months it is overwhelmed by macro. If the dollar stays firm or global growth softens, SCHE’s higher beta and deeper drawdown history should keep it lagging despite the better headline yield. The reverse setup is a weaker USD, Fed easing, or fresh China stimulus, which could let SCHE outperform materially over 6-18 months as EM earnings leverage finally gets credit.

Second-order, URTH ownership is effectively a call on AAPL/MSFT/NVDA/TSM more than on “international equities,” so flows into URTH are not broad developed-market bullishness so much as semi/AI concentration. SCHE’s mix makes it more exposed to BABA/TCEHY and Taiwan supply-chain sentiment, but those names are driven more by policy and capex cycles than by ETF demand. Consensus may be overestimating the permanence of URTH’s recent relative strength; the fee gap is real, but not enough to offset macro regime risk unless the dollar turns lower.